Article Details

Moderna's RSV Vaccine Efficacy Declines Faster Than Rivals, Stock Drops by 7% - Medriva

Retrieved on: 2024-02-10 14:21:19

Tags for this article:

Click the tags to see associated articles and topics

Moderna's RSV Vaccine Efficacy Declines Faster Than Rivals, Stock Drops by 7% - Medriva. View article details on hiswai: https://medriva.com/covid-19/modernas-rsv-vaccine-efficacy-declines-faster-than-rivals-stock-drops-by-7/

Excerpt

Analysts at Cowan studied follow-up data from Moderna's Phase 3 mRNA vaccine trial for RSV. They discovered that its efficacy dwindles faster than ...

Article found on: medriva.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up